How cannabinoids work
What is LOX enzymes?
A simple explanation of LOX enzymes, why cannabinoid researchers study it, and what its biology can and cannot tell us.
The short answer
Where LOX enzymes fits into cannabinoid biology
LOX enzymes is a biological target studied to understand how cannabinoids affect cells and signaling. Research on CBG, Anandamide, and Endocannabinoids helps explain possible mechanisms. This page brings together 1 human-study source, 3 research reviews, and 1 lab, animal, or mechanism source. Most of the current evidence is preclinical or focused on biological mechanisms. A mechanism alone does not prove that a cannabinoid will produce a health benefit in people. 1
Key takeaways
What to know first
- 1
Research on LOX enzymes covers CBG, Anandamide, and Endocannabinoids; those areas should not be combined into one claim. 1
- 2
Most of the current evidence is preclinical or focused on biological mechanisms. 2
- 3
Dose, formulation, route, study population, and outcome can change how closely a study applies to a real-world question. 3
Research areas
What researchers studied about LOX enzymes
These are the main questions represented in the current literature. Each link opens a source used to build the overview.
Mostly preclinical
CBG
Studies examine how CBG connects with LOX enzymes or closely related target biology. These findings help explain signaling and pharmacology, not a guaranteed health effect. 2
Too limited for a firm answer
Anandamide
Studies examine how Anandamide connects with LOX enzymes or closely related target biology. These findings help explain signaling and pharmacology, not a guaranteed health effect. 1
Mostly mechanism-focused
Endocannabinoids
Studies examine how Endocannabinoids connects with LOX enzymes or closely related target biology. These findings help explain signaling and pharmacology, not a guaranteed health effect. 3
How strong is the research?
Not every study answers the same question
This page separates research in people, research reviews, and earlier-stage biology before interpreting the larger question.
Human studies
Research involving people is closest to everyday health questions. The product, dose, population, and outcome still determine what each study can show.
Reviews and evidence summaries
Reviews can compare several studies at once. Their conclusion is only as strong and as relevant as the studies they include.
Lab, animal, and mechanism research
Early-stage research can explain biological interest. It cannot, by itself, show that the same effect happens in people.
What these studies actually looked at
The research on LOX enzymes is not one kind of study. This source set includes 3 narrative or expert reviews and 2 animal studies. 3
The recorded populations or models include animal models (1 source), cells or tissue models (1 source), and people or patients (1 source). A result from one group or model should not be assumed to apply to another. 4
The most common recorded outcome focus is anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms (3 sources), inflammation-related or immune outcomes (1 source), and tRPV4 channel activity, binding, signaling, or pharmacology (1 source). Closely related outcome names can still describe different measurements. 5
The LOX enzymes source set also contains findings or reviews that remain too limited, indirect, or mixed for a broad answer. That uncertainty is part of the result, not an empty space to fill with assumptions. 1
Examples from the literature
What did the studies actually look at?
Each example names the research question and the study details recorded for that source.
narrative or expert review
Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities.
On this page, this source examines Anandamide and anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. 1
- Study type
- narrative or expert review
- Outcome focus
- anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms
- Evidence stage
- evidence still limited
animal study
Cannabigerol as an anti-inflammatory agent altering the level of arachidonic acid derivatives in the colon tissue of rats subjected to a high-fat high-sucrose diet.
On this page, this source examines CBG and inflammation-related outcomes. 2
- Study type
- animal study
- Population or model
- animal models
- Outcome focus
- inflammation-related or immune outcomes
- Evidence stage
- preclinical research
animal study
Role of endothelial TRPV4 channels in vascular actions of the endocannabinoid, 2-arachidonoylglycerol.
On this page, this source examines Endocannabinoids activity involving TRPV4. 3
- Study type
- animal study
- Population or model
- people or patients
- Outcome focus
- tRPV4 channel activity, binding, signaling, or pharmacology
- Evidence stage
- mechanism-focused research
narrative or expert review
Endocannabinoid metabolism by cytochrome P450 monooxygenases.
On this page, this source examines Anandamide and anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. 4
- Study type
- narrative or expert review
- Outcome focus
- anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms
- Evidence stage
- evidence still limited
narrative or expert review
Metabolism of endocannabinoids.
On this page, this source examines Anandamide and anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms. 5
- Study type
- narrative or expert review
- Population or model
- cells or tissue models
- Outcome focus
- anandamide biology, receptor pharmacology, metabolism, physiology, or safety-relevant mechanisms
- Evidence stage
- evidence still limited
Safety and limits
What should readers keep in mind?
Research on LOX enzymes should be read beside safety. A compound can be non-intoxicating or naturally occurring and still have pharmacologic effects, side effects, interactions, or product-quality concerns. 1
Research doses are descriptions of what a study tested. They are not personal dosing instructions. Questions involving medications, pregnancy, children, driving, liver health, heart health, or serious symptoms deserve professional medical guidance.
Common questions
Questions people ask
What does LOX enzymes do?
LOX enzymes is studied as part of cannabinoid-related biology and signaling. The exact role depends on the tissue, compound, and experimental setting. 2
Does a biological mechanism prove a health effect?
No. A mechanism can explain why an idea is plausible, but human studies are needed to test whether it changes a health outcome. 3
What research is linked to LOX enzymes?
The main areas on this page include CBG, Anandamide, and Endocannabinoids. The source links show the study type behind each area. 4
Sources
Read the research
The numbered sources below support the main overview. Links open the PubMed record or DOI in a new tab.
-
1
Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities. narrative or expert review; evidence still limited PubMed 36150527 DOI 10.1016/j.plipres.2022.101194
-
2
Cannabigerol as an anti-inflammatory agent altering the level of arachidonic acid derivatives in the colon tissue of rats subjected to a high-fat high-sucrose diet. animal study; preclinical research PubMed 39128189 DOI 10.1016/j.biopha.2024.117286
-
3
Role of endothelial TRPV4 channels in vascular actions of the endocannabinoid, 2-arachidonoylglycerol. animal study; mechanism-focused research PubMed 26294342 DOI 10.1111/bph.13312
-
4
Endocannabinoid metabolism by cytochrome P450 monooxygenases. narrative or expert review; evidence still limited PubMed 25461979 DOI 10.1016/j.prostaglandins.2014.11.002
-
5
Metabolism of endocannabinoids. narrative or expert review; evidence still limited PubMed 27516570 DOI 10.5604/17322693.1213898
See all 5 research sources
This complete source list is the deeper research layer for the page. Study type and evidence context are shown when they are available in the current record.
- Cannabigerol as an anti-inflammatory agent altering the level of arachidonic acid derivatives in the colon tissue of rats subjected to a high-fat high-sucrose diet. animal study; preclinical research / 1 linked research note PubMed 39128189
- Role of endothelial TRPV4 channels in vascular actions of the endocannabinoid, 2-arachidonoylglycerol. animal study; mechanism-focused research / 1 linked research note PubMed 26294342
- Anandamide and other N-acylethanolamines: A class of signaling lipids with therapeutic opportunities. narrative or expert review; evidence still limited / 1 linked research note PubMed 36150527
- Metabolism of endocannabinoids. narrative or expert review; evidence still limited / 1 linked research note PubMed 27516570
- Endocannabinoid metabolism by cytochrome P450 monooxygenases. narrative or expert review; evidence still limited / 1 linked research note PubMed 25461979